Avelumab

Red

Brand Name(s):Bavencio

Indication:Merkel cell carcinoma (metastatic)

Rationale:1,2,3

Considered:Oct-17

Review Date:Nov-24

Comments:
SPC has been updated with additional information regarding the new licensed indication – in combination with axitinib, avelumab is licensed for the first-line treatment of adult patients with advanced renal cell carcinoma